Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, AVO

Mobile Rapid Response Teams Among Other Measures Recommended to Tackle Regional COVID-19 Flare-ups


TORONTO, Sept. 30, 2020 /CNW/ - As the number of COVID-19 cases continues to spike, the Ontario Medical Association (OMA) is recommending the immediate creation of mobile rapid response teams to quickly identify and contain localized flare-ups.

Today, the OMA released A Prescription for Ontario: Maintaining Vigilance as We Learn to Live with COVID-19, a plan which contains recommendations for both the public and the government. The plan addresses our need to minimize the spread of COVID-19 while also tackling the ongoing backlog of medical services. As we go forward it is important to understand that success is a shared responsibility between government and individuals - everyone has a role to play.

The OMA is urging the government to:

"Mobile rapid response teams will place skills and equipment where they are most needed, while allowing capacity within the system to address the backlog of patient services and better prepare for the flu season," said OMA President Dr. Samantha Hill. "Ontario doctors are deeply concerned about the dramatic rise in the number of COVID-19 cases and are calling on the government to move quickly to contain the spread of the virus and take a regional approach rather than a province-wide one. Timely, graduated and proportionate responses to localized outbreaks will ensure resources are preserved for where they are most needed, a dimmer-switch instead of a sledgehammer."

Dr. Hill said the pandemic is a fluid and constantly changing situation that will vary by region, population and even individuals. "We should not expect the "new normal" to be a return to our pre-COVID normal; the situation will continuously change as the pandemic evolves and the system responds," she said. "That means all of us must be aware and ready to adapt to changing circumstances, guidance and recommendations."

In addition, the OMA is recommending that individuals:

"Tackling COVID-19 is a shared responsibility between all parts of the system and individuals and we are pleased to release a full plan that addresses all sides," said OMA CEO Allan O'Dette. "As localized outbreaks increase, the role and expertise of regional and local public health officials is more important that ever. Ontario's doctors will continue to work with them and with all stakeholders to protect Ontarians during this pandemic and provide them with the best possible care."

 About the OMA

The Ontario Medical Association represents Ontario's 43,000 plus physicians, medical students and retired physicians, advocating for and supporting doctors while strengthening the leadership role of doctors in caring for patients. Our vision is to be the trusted voice in transforming Ontario's health-care system. 

SOURCE Ontario Medical Association


These press releases may also interest you

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

at 16:20
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales...

at 16:16
A functional assessment of Bacillus subtilis PLSSC (SEBtilistm) demonstrated its antimicrobial activity and capability to offer health benefits through industrial processing and the digestion process, showing its value-add in functional foods,...

at 16:15
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...



News published on and distributed by: